Skip to main content

New Products: Life Tech's AmpliSeq Exome; Swift Biosciences' Accel-NGS; Genome-euro

Premium

Life Technologies' Ion Torrent has launched AmpliSeq Exome kit. The kit uses 300,000 amplicons and can complete an exome capture in six hours with one hour of hands-on time and requires sample input of 50 nanograms, according to the company (see story, this issue).


Swift Biosciences is offering an early access program for its Accel-NGS Library Kit for Illumina's sequencing systems. According to the company, the kit enables PCR-free libraries with 250 nanograms of input DNA and is compatible with formalin-fixed paraffin-embedded tissue and damaged samples. Turnaround time is around 90 minutes.


The University of California, Santa Cruz Genome Browser has launched Genome-euro, a mirror site of the UCSC Genome Browser that is intended to serve users in Europe. The server is located in Universität Bielefeld Center for Biotechnology in Bielefeld, Germany, and is administered by UCSC. All functionality will be the same as on the US server.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.